1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77(12 II):7415–9.
2. Norouzi M, Zarei Ghobadi M, Golmimi M, Mozhgani SH, Ghourchian H, Rezaee SA. Quantum Dot-Based Biosensor for the Detection of Human T-Lymphotropic Virus-1. Anal Lett. 2017;50(15):2402–11.
3. Fani M, Rezayi M, Meshkat Z, Rezaee SA, Makvandi M, Abouzari-Lotf E, et al. Current approaches for detection of human T-lymphotropic virus Type 1: A systematic review. J Cell Physiol. 2019;234(8):12433–41.
4. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A. 1982;79(6 I):2031–5.
5. Gessain A, Vernant JC, Maurs L, Barin F, Gout O, Calender A de, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;326(8452):407–10.
6. Morgan OS, Mora C, Rodgers-Johnson P, Char G. HTLV-1 AND POLYMYOSITIS IN JAMAICA. Lancet [Internet]. 1989;334(8673):1184–7.
7. Nishioka K. HTLV-I Arthropathy and Sjögren Syndrome. JAIDS J Acquir Immune
Defic Syndr 1996;13.
8. Nishioka K. Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1989;1:441.
9. Gonçalves DU, Proietti FA, Ribas JGR, Araújo MG, Pinheiro SR, Guedes AC, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1associated diseases. Clin Microbiol Rev. 2010;23(3):577–89.
10. Bangham CRM. Human T Cell Leukemia Virus Type 1: Persistence and Pathogenesis. Annu Rev Immunol. 2018;36(November 2017):43–71.
11. Kubota R. Pathogenesis of human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis. Clin Exp Neuroimmunol. 2017;8(2):117– 28.
12. Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CRM. HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood.
13. 2012;120(17):3488–90
14. Yamano Y, Nagai M, Brennan M, Mora CA, Soldan SS, Tomaru U, et al. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1associated myelopathy (HAM/TSP). Blood. 2002;99(1):88–94.
15. Enose-Akahata Y, Vellucci A, Jacobson S. Role of HTLV-1 Tax and HBZ in the pathogenesis of HAM/TSP. Front Microbiol. 2017;8(DEC):1–10.
16. Nozuma S, Kubota R, Jacobson S. Human T-lymphotropic virus type 1 (HTLV-)1 and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis. J Neurovirol. 2020;26(5):652–63.
17. Melamed A, Laydon DJ, Khatib H Al, Rowan AG, Taylor GP, Bangham CRM. HTLV ‑ 1 drives vigorous clonal expansion of infected CD8 + T cells in natural infection. Retrovirology. 2015;4–13.
18. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Jr WH, et al.
Definition , Prognostic Factors , Treatment , and Response Criteria of Adult T-Cell Leukemia-Lymphoma : A Proposal From an International Consensus Meeting. 2009;27(3):453–9.
19. Mozhgani SH, Zarei-Ghobadi M, Teymoori-Rad M, Mokhtari-Azad T, Mirzaie M, Sheikhi M, et al. Human T-lymphotropic virus 1 (HTLV-1) pathogenesis: A systems virology study. J Cell Biochem. 2018;119(5):3968–79.
20. Aye MM, Matsuoka E, Moritoyo T, Umehara F, Suehara M, Hokezu Y, et al. Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spastic paraparesis: Inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol. 2000;100(3):245–52.
21. Takenouchi N, Yamano Y, Usuku K, Osame M, Izumo S. Usefulness of Proviral Load Measurement for Monitoring of Disease Activity in Individual Patients with
Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis. J Neurovirol. 2003;9(1):29–35. Available from:
https://www.tandfonline.com/doi/abs/10.1080/13550280390173418
22. Hayashi D, Kubota R, Takenouchi N, Nakamura T, Umehara F, Arimura K, et al. Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I - Associated myelopathy. J Neurovirol. 2008;14(5):459–63.
23. Keshvari M, Hajibeigi B, Azarkeivan A, Keyvani H, Behnava B, Saiedi Hosseini SY, et al. Seroepidemiology of human T-cell lymphotropic virus among Iranian adult thalassemic patients. Transfus Med. 2014;24(4):227–32.
24. Abedi F, Mozhgani SH, Rahimzadegan M, Gudarzi H, Valizadeh N, Rezaee SA. Prevalence and phylogenic study of human T-lymphotropic virus 1 in patients with thalassemia in the northeast of Iran. Future Virol. 2017;12(5):253–8.
25. Vermeulen M, Sykes W, Coleman C, Custer B, Jacobs G, Jaza J, et al. The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors. Vox Sang. 2019;114(5):451–8.
26. Fani M, Rezayi M, Meshkat Z, Rezaee SA, Makvandi M, Ahmadi Angali K. A
Novel Electrochemical DNA Biosensor Based on a Gold Nanoparticles-Reduced Graphene Oxide-Polypyrrole Nanocomposite to Detect Human T-Lymphotropic Virus-1. IEEE Sens J. 2020;20(18):10625–32.
27. Yara S, Fujita J, Date H. Transmission of human T-lymphotropic virus type I by bilateral living-donor lobar lung transplantation. J Thorac Cardiovasc Surg
[Internet]. 2009;138(1):255–6. Available from: http://dx.doi.org/10.1016/j.jtcvs.2008.12.050
28. Cassar O, Gessain A. Serological and molecular methods to study epidemiological aspects of human T-cell lymphotropic virus type 1 infection. Methods Mol Biol. 2017;1582:3–24.
29. Hedayati-Moghaddam MR. A systematic review for estimation of HTLV-I infection in the blood donors of Iran. Iran J Basic Med Sci. 2013;16(3):196–201.
30. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: A population-based seroepidemiology survey. J Clin Virol.2011;52(3):172–6.
31. Franco-Paredes C, Jacob JT, Hidron A, Rodriguez-Morales AJ, Kuhar D, Caliendo AM. Transplantation and tropical infectious diseases. Int J Infect Dis. 2010;14(3):e189–96.
32. Rafatpanah H, Torkamani M, Valizadeh N, Vakili R, Meshkani B, Khademi H, et al. Prevalence and phylogenetic analysis of HTLV-1 in a segregated population in Iran. J Med Virol. 2016;88(7):1247–53.
33. Satake M, Iwanaga M, Sagara Y, Watanabe T, Okuma K, Hamaguchi I. Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in
Japan: a nationwide retrospective cohort analysis. Lancet Infect Dis. 2016;16(11):1246–54.
34. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, et al. Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp. J Neurovirol. 1998;4(6):586–93.
35. Einsiedel LJ, Pham H, Woodman RJ, Pepperill C, Taylor KA. The prevalence and clinical associations of HTLV-1 infection in a remote Indigenous community. Med J Aust. 2016;205(7):305–9.
36. Salehi M, Mostafavi SKS, Ghasemian A, Gholami M, Kazemi-Vardanjani A, Rahimi MK. Seroepidemiology of HTLV-1 and HTLV-2 infection in Neyshabur city, North-Eastern Iran, during 2010-2014. Iran Biomed J. 2017;21(1):57–60.
37. Azarpazhooh MR, Hasanpour K, Ghanbari M, Rezaee SAR, Mashkani B, HedayatiMoghaddam MR, et al. Human t-lymphotropic virus type 1 prevalence in northeastern Iran, sabzevar: An epidemiologic-based study and phylogenetic analysis. AIDS Res Hum Retroviruses. 2012;28(9):895–901.
38. Safabakhsh H, Jalalian M, Karimi G. Seroepidemiology of human T-cell lymphotropic virus type-1 (HTLV1) in Mashhad. Glob J Health Sci. 2014;6(5):99– 104.
39. Desdouits M, Cassar O, Maisonobe T, Desrames A, Aouba A, Hermine O, et al. HTLV-1-associated inflammatory myopathies: Low proviral load and moderate inflammation in 13 patients from West Indies and West Africa. J Clin Virol .2013;57(1):70–6.
40. Jalaeikhoo H, Soleymani M, Rajaeinejad M, Keyhani M. Prevalence of human Tlymphotropic virus type 1 (HTLV-1) infection in patients with hematologic disorders and non-hematologic malignancies in a tertiary referral hospital. Arch Iran Med. 2017;20(4):224–8.
41. Li HC, Biggar RJ, Miley WJ, Maloney EM, Cranston B, Hanchard B, et al. Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis. 2004;190(7):1275–8.
42. Roucoux DF, Wang B, Smith D, Nass CC, Smith J, Hutching ST, et al. A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J Infect Dis. 2005;191(9):1490–7.
43. Mozhgani SH, Kermani HA, Norouzi M, Arabi M, Soltani S. Nanotechnology based strategies for HIV-1 and HTLV-1 retroviruses gene detection. Heliyon. 2020;6(5):e04048.
44. Ghobadi MZ, Mozhgani SH, Hakimian F, Norouzi M, Rezaee SA, Ghourchian H. Long segment detection of HTLV-1 genome based on the fluorescence quenching technique. Heliyon. 2018;4(12):e00996.
45. Zarei-Ghobadi M, Mozhgani SH, Dashtestani F, Yadegari A, Hakimian F, Norouzi M, et al. A genosensor for detection of HTLV-I based on photoluminescence quenching of fluorescent carbon dots in presence of iron magnetic nanoparticle-capped Au. Sci Rep. 2018;8(1):1–8.
46. Fani M, Rezayi M, Pourianfar HR, Meshkat Z, Makvandi M, Gholami M, et al. Rapid and label-free electrochemical DNA biosensor based on a facile one-step electrochemical synthesis of rGO–PPy–(L-Cys)–AuNPs nanocomposite for the HTLV-1 oligonucleotide detection. Biotechnol Appl Biochem. 2021;68(3):626–35.
47. Vikrant K, Bhardwaj N, Bhardwaj SK, Kim KH, Deep A. Nanomaterials as efficient platforms for sensing DNA. Biomaterials. 2019;214(May).
48. Shi XM, Fan GC, Tang X, Shen Q, Zhu JJ. Ultrasensitive photoelectrochemical biosensor for the detection of HTLV-I DNA: A cascade signal amplification strategy integrating λ-exonuclease aided target recycling with hybridization chain reaction and enzyme catalysis. Biosens Bioelectron [Internet]. 2018;109(February):190–6.
49. Takatsuki K. Adult T cell leukemia in Japan. Top Hematol. 1977 [cited 2022 Aug 2];73–7.
50. Matsuoka M, Mesnard JM. HTLV-1 bZIP factor: the key viral gene for pathogenesis. Retrovirology. 2020 Dec;17(1):1-8.
مجله دانشگاه علوم پزشکی نیشابور